fludarabine phosphate has been researched along with Central Nervous System Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caryk, SM; Chun, HG; Hoth, DF; Leyland-Jones, BR | 1 |
| Griffin, NL; Kagan-Hallet, K; Merkel, DE; Von Hoff, DD | 1 |
2 other study(ies) available for fludarabine phosphate and Central Nervous System Diseases
| Article | Year |
|---|---|
Central nervous system toxicity of fludarabine phosphate.
Topics: Acute Disease; Adult; Aged; Antimetabolites, Antineoplastic; Arabinonucleotides; Blindness; Brain Diseases; Central Nervous System Diseases; Child; Drug Evaluation; Electroencephalography; Female; Humans; Leukemia; Male; Middle Aged; Tomography, X-Ray Computed; Vidarabine Phosphate; Vision Disorders | 1986 |
Central nervous system toxicity with fludarabine.
Topics: Adult; Aged; Arabinonucleotides; Autopsy; Central Nervous System Diseases; Dose-Response Relationship, Drug; Female; Humans; Male; Time Factors; Vidarabine Phosphate | 1986 |